PRJNA685554
Effects of inhaled corticosteroid/long acting beta-2 agonist combinations on the airway microbiome of patients with COPD: a randomised controlled trial (DISARM)
This study analyzed bronchial brushing samples collected from patients with Chronic Obstructive Pulmonary Disease (COPD) to compare the effects of two inhaled corticosteroids (budesonide and fluticasone) on the lung microbiome.